Search results

Jump to navigation Jump to search
Results 1 – 50 of 123
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Did you mean: with monoamine
  • Physician. 76 (8): 1169–1174. ISSN 0002-838X.  https://en.wikipedia.org/wiki/Monoamine_releasing_agent#Activity_profiles Kirkpatrick, M. G., Gunderson, E.
    41 KB (5,798 words) - 13:29, 16 April 2024
  • ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    6 KB (1,847 words) - 00:06, 16 May 2024
  • reports as of March 2015. AMT - Deaths from AMT are rare. But as a powerful monoamine reuptake inhibitor (MRI), injury could occur when excessive doses are taken
    19 KB (2,209 words) - 23:08, 21 April 2024
  • of an indole ring with attached amino group via a two-carbon sidechain (monoamine chain) at R3. Ring unsubstituted tryptamines, or so called "base tryptamines"
    10 KB (461 words) - 23:05, 21 April 2024
  • acuminata - DMT-Nexus Wiki  Acacia baileyana Wikipedia | https://en.wikipedia.org/wiki/Acacia_baileyana Acacia baileyana - DMT-Nexus Wiki  Acacia burkittii
    70 KB (630 words) - 04:11, 16 May 2024
  • amine-associated receptor 1 (TAAR1) and vesicular monoamine transporter 2 (VMAT2). MDMA is a monoamine transporter substrate (i.e. a substrate for the transporters
    85 KB (10,499 words) - 14:24, 16 April 2024
  • info - Home  https://psychonautwiki.org/wiki/File:Behandeling-4-fa-intoxicatie.pdf https://psychonautwiki.org/wiki/File:4-FA%20risicobeoordeling%20(2016)
    21 KB (3,439 words) - 15:42, 30 July 2022
  • 6-APB also possesses additional activity as a releasing agent of these monoamine neurotransmitters. 6-APB is a potent full agonist of the serotonin 5-HT2B
    33 KB (4,870 words) - 14:34, 16 April 2024
  • March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain". European Journal of Pharmacology. 559
    21 KB (3,467 words) - 16:14, 30 July 2022
  • trace amine-associated receptor 1 (TAAR1) and interacts with vesicular monoamine transporter 2 (VMAT2). Combined action on TAAR1 and VMAT2 results in increased
    41 KB (5,610 words) - 19:01, 7 April 2024
  • In order to maintain consistency across the wiki, images of molecular structures should be produced in a standardized format rather than obtained from
    19 KB (857 words) - 09:55, 15 September 2022
  • much they interact with other medications. MAOIs block the effects of monoamine oxidase enzymes, thereby increasing the concentration of dopamine, norepinephrine
    9 KB (1,069 words) - 21:47, 13 May 2024
  • (which is a monoamine closely related to serotonin) is rendered almost entirely inactive when digested by itself due to the presence of monoamine oxidase enzymes
    33 KB (3,884 words) - 07:33, 16 November 2023
  • for Drugs and Drug Addiction. Retrieved December 27, 2019.  MDPV - TripSit wiki  https://www.deadiversion.usdoj.gov/drug_chem_info/mdpv.pdf http://www.who
    23 KB (3,267 words) - 23:45, 21 April 2024
  • than older antidepressants like monoamine oxidase inhibitors and tricyclic antidepressants.[citation needed] Monoamine oxidase inhibitors also interact
    15 KB (1,687 words) - 18:59, 22 November 2023
  • (1986). "Studies of Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase II. Inhibition by α-Methylated Substrate-Analogue Monoamines, α-Methyltryptamine
    25 KB (2,825 words) - 16:14, 28 November 2022
  • ortho-oriented relative to each other. A monoamine chain is made up of an amine group attached to an ethane chain. This monoamine chain can be found in many neurotransmitters
    5 KB (628 words) - 23:12, 21 April 2024
  • food containing tyramine and other substances with monoamine moieties which are reliant on monoamine oxidase for decomposition. However, it is important
    13 KB (1,772 words) - 02:21, 24 September 2023
  • from TripSit. Amphetamines - Stimulants facilitate the activity of the monoamine neurotransmitters, i.e., dopamine, norepinephrine and serotonin, in the
    22 KB (3,211 words) - 19:11, 7 April 2024
  • ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    27 KB (1,991 words) - 18:31, 18 September 2022
  • administered bufotenin undergoes extensive first-pass metabolism by the enzyme monoamine oxidase. Bufotenin's psychedelic effects are primarily believed to come
    16 KB (2,273 words) - 19:54, 7 April 2024
  • 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
    the 2,5-desmethoxy derivative of 2C-T-7) are known to act as selective monoamine oxidase A inhibitors.[citation needed] Furthermore, many compounds of the
    22 KB (2,627 words) - 23:08, 29 May 2021
  • transporters is similar. Notably, methylone's affinity for the vesicular monoamine transporter 2 (VMAT2) is about 13x lower than that of MDMA. The result
    19 KB (2,841 words) - 14:21, 16 April 2024
  • produces long-lasting euphoric and stimulating effects associated with potent monoamine reuptake inhibitors when administered. It is a closely related structural
    17 KB (2,757 words) - 17:49, 30 July 2022
  • (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    21 KB (2,634 words) - 00:21, 11 December 2023
  • have characterised 3-FEA as a moderately potent serotonin-dominant triple monoamine releaser that produces a mixture of entactogenic and mild stimulating effects
    19 KB (3,317 words) - 15:23, 30 July 2022
  • ingested along with an inhibitor of monoamine oxidase. Because DET has ethyl groups attached to its nitrogen atom, monoamine oxidase is unable to degrade it
    14 KB (1,584 words) - 04:58, 30 June 2022
  • 6-APB and broadly shares the characteristics of serotonin-selective triple monoamine releasers and reuptake inhibitors associated with other entactogenic or
    26 KB (4,015 words) - 23:44, 21 April 2024
  • substances are believed to have very similar pharmacological mechanisms as monoamine reuptake inhibitors but have been reported to display distinctive subjective
    16 KB (2,465 words) - 15:45, 9 May 2024
  • ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity". Behavioural Pharmacology. 18 (1): 39–51
    18 KB (2,561 words) - 14:02, 16 April 2024
  • next day. Melatonin is comprised of a monoamine chain attached to an indole ring at the third carbon. A monoamine chain is made up of an amine group attached
    15 KB (1,896 words) - 23:12, 21 April 2024
  • SNRI Synthetic cannabinoids Vagus nerve Hormone Neuron Neurotransmitter Monoamine Receptor Synapse Blood–brain barrier Serotonin Dopamine Glutamate NMDA
    599 bytes (162 words) - 23:00, 21 April 2024
  • (June 1988). "[Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats]". Farmakologiia
    11 KB (1,427 words) - 22:01, 24 January 2024
  • dependence and withdrawals have been documented. monoamine oxidase inhibitors or reversible inhibitors of monoamine oxidase could potentially boost the actions
    10 KB (1,095 words) - 23:12, 9 May 2024
  • any substance which acts as a releasing agent or reuptake inhibitor of monoamine neurotransmitters. 5-MeO-DMT is O-demethylated by polymorphic cytochrome
    26 KB (3,619 words) - 19:56, 7 April 2024
  • eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183.  Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British
    13 KB (2,233 words) - 00:32, 31 December 2022
  • transporter. This substance acts as a triple reuptake inhibitor and prevents monoamine neurotransmitters from being recycled, causing excessive amounts to build
    20 KB (2,747 words) - 00:19, 1 August 2022
  • damage in children. In rodents and primates, sufficiently high doses of monoamine releasing agents cause dopaminergic neurotoxicity, or damage to dopamine
    19 KB (2,675 words) - 16:54, 31 March 2024
  • far characterized 3-FMA as a moderately potent serotonin-dominant triple monoamine releaser (or reuptake inhibitor) that produces a relatively short-lived
    14 KB (2,687 words) - 15:28, 30 July 2022
  • eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183.  Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British
    12 KB (1,928 words) - 23:42, 21 April 2024
  • excessive stimulation. There are no known deaths from 5-MeO-MiPT but, as a monoamine reuptake inhibitor (MRI), injury could occur when excessive doses are taken
    22 KB (2,938 words) - 21:31, 14 November 2023
  • animals treated with MDAI have greater extracellular concentrations of monoamine neural transmitters, most significantly serotonin.[citation needed] For
    17 KB (2,560 words) - 07:40, 12 October 2023
  • studies have found stimulatory effects; in vitro studies have evaluated the monoamine transporter binding affinities and affinities for various hydrolytic enzymes
    19 KB (2,684 words) - 18:04, 30 July 2022
  • reuptake inhibitor. This means that it effectively boosts the levels of the monoamine neurotransmitters serotonin, norepinephrine, and dopamine in the brain
    18 KB (2,590 words) - 21:20, 30 April 2024
  • olidin-1-yl-pentan-1-one (Pyrovalerone) analogs. A promising class of monoamine uptake inhibitors". Journal of medicinal chemistry. 49 (4): 1420–1432.
    21 KB (3,212 words) - 09:58, 30 May 2023
  • eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183.  Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British
    31 KB (4,254 words) - 15:15, 6 May 2024
  • eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183.  Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British
    14 KB (2,336 words) - 23:43, 21 April 2024
  • they are not placed in the recovery position. MAOIs - Coadministration of monoamine oxidase inhibitors (MAOIs) with certain opioids has been associated with
    19 KB (2,797 words) - 02:47, 12 May 2024
  • members of the phenidate class, methylnaphthidate is believed to act as a monoamine reuptake inhibitor.[citation needed] However, it has been reported to display
    9 KB (1,564 words) - 23:45, 21 April 2024
  • the 2,5-desmethoxy derivative of 2C-T-7 has been shown to be a moderate monoamine oxidase A inhibitor and many of the amphetamine-analogs of the 2C-T-x series
    22 KB (2,709 words) - 23:09, 29 May 2021

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)